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Amyloid precursor protein (APP) gene xpression was invcstigarcd inprimary cultures ol’ncurons, aslrocytcs, microglial cells and oligodendrocyks. 
Neurons from various rat brain regions, as well as oligodendrocytcs, contained RNA encoding APP,,, while aslrocytcs and microglial cells 
expressed high levels of RNAs for APP,,O and APP ,,,, It was sludicd whether the cell type-specific regulation of APP gene expression could be 
modified by induction of cellular diffcrentialion in vitro. While ncuronal differentiation of PC12 cells has been shown 10 correspond wilh an altered 
pattern of APPsplicing, in the primary cuhurcs neither the time in culture nor a trealmcnl of thccclls with appropriatedilTerenliation factorsaktcd 
[his paltern. 
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1. INTRODUCTION 
Alzheimer’s disease (AD‘) is correlated with massive 
deposition of fibrillar aggregates of the PA4 protein in 
the brain Cl]. This protein is derived by proteolysis from 
a large transmembrane precursor protein, the PA4 pre- 
cursor protein (APP). Three major forms of APP tran- 
scripts have been identified, which code for precursor 
proteins with 695, 751 and 770 amino acids. The two 
larger isoforms contain a sequence homologous to pro- 
tease inhiiiitors of the Kunitz type. Gene analysis has 
revealed that the different APP transcripts arise from a 
single gene by alternative splicing [2-4]. 
deposits is still unclear; based on their distribution they 
are most likely produced by neurons [9-l 11. Since histo- 
pathology of AD is accompanied by reactive gliosis, 
however, the participation of activated astrocytes and 
microglia in APP synthesis and generation ofpA must 
be taken into account [12,13]. 
These observations encouraged studies to investigate 
whether the levels and ratios of APP transcripts in AD 
brains differ from control brains. Alterations in the 
abundance of specific APP transcripts are discussed as 
a mechanism leading to the generation of the mature 
pA4. 
We decided, therefore, to use individu:! ,211 types of 
the CNS to investigate xpression and splicing of APP 
in vitro. For the relative quantification of APP splice- 
forms we used PCR amplification of APP cDNA [7] 
from primary cultures of neurons (from cortex, hip- 
pocampus, septum, substantia nigra and rostra1 raphe), 
cortical astrocytes, micro&a and oligodendrocytes. To 
mimic the in vivo situation of reactive gliosis, astrocytes 
were activated with bFGF or CAMP [14], and microglial 
cells with LPS, a highly potent activator of macroph- 
ages [151. Neurons were studied with respect to their age 
in culture and to the influence of appropriate survival 
and differentiation factors. 
APP is secreted from many cell types by the cleavage 
at a site which is located within thr PA4 sequence [5,6]. 
This proteolysis can therefore not be responsible for the 
production of the mature protein and an alternative 
pathway for APP processing is likely to exist. In situ 
hybridization and PCR studies demonstrating the over- 
expression of API+;, in white matter of AD patients 
[7,8] implied that the increased expression of APP con- 
taining the Kunitz type protease inhibitor domain could 
favour the generation of PA4 by blocking the normal 
proteolytic pathway. The cellular origin of the amyloid 
2. MATERIALS AND METHODS 
Media and other sterile solutions wcrc either from Gibco or Flow 
Laboratories. and Nu-strum was from Collaborative Rcscarch. Bc+ 
vine recombinant basic fibroblasr growth factor and mouse GFAP- 
antibody were from Bochringer. 01. a mouse monoclonal anlibody. 
was a gill from M. Schachncr, Ziirich. Other immunochemicals were 
from Vector Laboratories. 
Correspondettce address: H. Lllbbert, Preclinical Research 386122ti. 
Sandoz Pharma Lrd., CM-4002 Basel, Switzerland. Fax: (41) (61) 324 
2141. 
2.2. Prqarur loft o~iterrrottaf ceff cuflures 
Primary cultures of neurons from septum, hippocampus and Q)IICX 
were prepared from rat lxain at embryonic day 17 [16]. Cultures or 
dopnmincrgic or scrolonergic neurons were isolated from the ventral 
mc%ncephalon or the rostra1 rhombuncephalon. respeclivcly. at El4 
Pubffsfted by Efsevier Science Pltbifsfters 8. V. 329 
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[ 17.18]. After dissection, the appropriate tissue picccs were dissociated 
by gentle tituration in Caz’/Mgz~F.frcc Dulbecco’s phosphate-buffered 
saline. The ceil suspension was centrifuged for 10 min at 200 x g, The 
cells were plated at a density of 3 x IO” viable cells per 16”mm well in 
24.~~11 plates precoatcd with 30 ,ug/ml of poly-o-lysinc. The culture 
medium Contained 70% Eagle’s minimum essential medium. 25% 
HBSS, 5% Nu.SCrum, 6 mg/ml glu~osc, 70 U/ml penicillin, und 0.07 
mg/ml streptomycin, Cultures were grown at 35°C in a 95% air/S% 
CO: humidified atmosphere, 
2.3. Priyai-ation of ostrocyte dtures 
Cultures were prepared from newborn Sprague-Dawley rats ac- 
cording to the method of Hertz et al. [19]. Brictly. after removal ofthc 
mcningcs, the Cerebral hemispheres wcru cut into 1 mm cubes and 
vortexed at maximum speed, The tissue was then dissociated by titura- 
&ion with a Pasteur pipette. After passing the czll suspessions through 
Nitcx meshes (&I-IO pm), cells were seeded in poly-o-lysine-coated 
culture dishes, These primary cultures were grown lo COnfluCnCy in
DMEM containing 10% FCS and then passagcd by trypsinisution. 
Cultures were characterized by GFAP immunocyiochemistry. 
LEP Scientific) using cycles consisting of dcnaturation at 94°C for 1 
min. rollowed by annealing at 59°C and primer extension at 72°C for 
2 min. The samples were separated on 4% agarosc gels, The gels were 
dried and exposed to X-ray films. The amount of DNA in the bands 
was quantified by cutting the bands from the dried gels and subsequent 
Ccrcnkov counting. 
Oligonucleotides were synthesized on an automated solid-phase 
synthesizer (Applied Biosystems 380B). The 20.mcr oliponucleotides 
used for PCR were passed lhrough Quick spin columns (Boehringcr), 
prccipilated with ethanol and dissolved in water. 
The sequence for :he forward primer was TAC- 
CACTGAGTCTGTGGAGG. corresponding tobases 834-853 of the 
APP,,, sequence [9]. The sequence of the reverse primer was 
GGGGGTCTCCAGGTACTTGT, complementary to bases 921-902 
of the ADPti5 sequence. 
3. RESULTS 
2.4. Prepurution 0~0liguclmIrocytrs 
Oligodendrocytes were prepared from mixed glial cultures isolated 
from nconatol rat cortex according to [20]. Arter 8 days in vitro 
cultures were washed once with Ca’+/Mg?*-free HBSS. Subsequently. 
cultures were shaken vigorously for 20 min in HBSS to remove the 
bipolar oligodcndrocylc precursor cells. The supernatants wcrc rc- 
plated at 2 x 10d cells/cm’ in poly.D=lysinC-coaled cullurc dishss. To 
obtain differcntinted oligodcndrocytcs, the cells were cultivated in 
DMEM containing 15 &$rnl insulin, 1 &/ml lrimsfcrrin and 30 nM 
sclenitc for several days. Mature oligodcndrocytes were identified as 
01-positive cells and rcprescnted about 60% of the total cell populu- 
tion. 
As an alternative method to obtain differentiated oligodrndrocytes 
we applied the purification from a crude suspension of glial cells on 
a percoll density gradient [?I]. A band formed, with a density beiaeen 
6 I.023 and 6 1.050, which delivered apopulation of almost pure Ol* 
oligodendrocytes (>90%). 
We used RT-PCR to examine the pattern of APP 
mRNA splicing in primary cultures of neurons, astro- 
cytes, microglia and oligodendrocytcs. The primers 
used for PCR flanked the alternative splice site [7]. They 
gave rise to PCR products of 87,255 and 3 12 bp, corre- 
sponding to the APPfigs, APPT5, and APPTI, mRNAs, 
respectively. The validity of this PCR method for the 
relative quantification of the APP slice forms has been 
demonstrated previously [7]. To ensure that it worked 
in our hand, we reproduced the well-characterized shift 
towards the expression of APPbg5 occurring in PC12 
cells [24] upon induction with NGF (data not shown). 
2.5. Prrporutio~i of r~kwgliul celfs 
Cultures of microglinl cells were prepared from newborn ICR mice 
as described in detail [22]. For isolation of microglial cells. conlluenr 
glial cell cultures between day I2 and I4 were vigorously shaken on 
a rotary shaker or 1 h. The floating cells were collected and cultured 
in 6-well tissue culture plates al a density of 1.5 x IO’ cclls/wcll in 
DMEM containing 5% PCS. After 2 h, ~hc non-adherent cells were 
washed out tlvo times with Hank’s balanced salt solution. The adher- 
ent microglial cells were nearly 100% pure when examined by non- 
specific stcrasc staining and immunofluorcsccncc with anti-C3b rc. 
ccptor antibodies (Mac. I, Scra Laboratory, Crawleydown, Sussex, 
GB) and anti-f, (IgGl/Zb) receptor antibodies (NEN, Boston, MA), 
We then ‘dnalysed primary cultures of neurons from 
different brain regions. Purity of the neuronal cultures 
was ensured by PCR analysis of the mRNAs with prim- 
ers for GFAP, delivering no positive signals (data not 
shown). GFAP is an intermediate filament protein spe- 
cific for astrocytes. Examining neurons from hippocam- 
2.6. W/i c.rtruction atid PCA (polymwse hill rcwtion) 
Total cellular RNA was extracted from ccl1 cultures by the acid 
phenol method [23]. 
Reverse transcription was performed using hexanucleotidcs as 
primers and M-MLY rcversc transcriptasc (BRL). The 20 ~1 reoction 
contained enzyme buffer (BRL), I 4 of RNA, IO0 pm01 of the TICS- 
anucleotidcs, IO U RNAsin (Promega), 200 lJ M-MLV RT, a11d 
dNTPs at a final concentration of SO0 ,uM. The rcuction ws tcrmi- 
oatcd after 1 h at 37°C. For PCR 1 ~1 of cDNA was used and the 
samples wcrc brought o a final concemru\ion of 1 G mM (NH,)&x& 
67 mM Tris-MCI, pH 8.8,6.5 mM M&I,, IO mM 2.mercuptocth:lnol. 
0.01% gelatin, 6.8 PM EDTA, 10% DMSO and 100 PM dNTPs. 
Additionally, the reaclion mixture (50 ~1) contained 20 pmol 01’ tile 
forward a;ld reverse primer and 2.5 Ll of Tuq DNA polymcrusc 
(Perkin Elmer Cetus). To monitor the rcuction. the forward prime1 
was 5’ cnd&beled with ??P using polynuclcotide kinusc (~gehringer). 
_I 
Hippoc. Cortex 
Fig. I, PCR analysis of APP mRNAs in neurons from hippocampus 
and cortex. Cells were cultivated for 4 h, 3 or 5 days, respectively. 
Total RNA was cxtrxtcd from cultured cells, reverse transcribed and 
amplified by 30 cycles of PCR with “P-lab&d APP-specific primers 
spanning the sites of differential splicing. The indicated fragments 
were generated by PCR. The slot on the left containd 0X 174DNA 
PCR was carried out in a programmsblc heating block (PREM 111. digested with NurIII us a marker. 
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Fig. 2. PCR analysis of APP mRNAs in neurons from substantia nigra 
(S.N.), rostra) raphe (R.R.) and seplum. Neurons were cultivaled for 
4 days in the absence or presence of bFGF (50 ngml), CAMP (I mM), 
or NGF (10 ndml). rcspcctivcly. Total RNA VW cxlracled, reverse 
transcribed and amplified with APPqxciJic primers. 
pus and cortex, we showed that APPbgS was exclusively 
expressed in these cultures. The two larger isoforms, 
APD,S, and APP,,“, could not be detected (Figs 1). This 
expression pattern did not change with time in culture 
(4 h, 3 or 5 days). 
Primary cultures of neurons from substantia nigra, 
rostra1 raphe and septum were also examined. PCR 
analysis of these neurons again revealed the expression 
of only the APPegS isoform (Fig. 2). Treatment of the 
different ypes of neurons with appropriate survival or 
differentiation factors (50 @ml of bFGF, 1 mM of 
db-CAMP, or 10 @ml of NGF, respectively) did not 
alter the splicing pattern of APP. The absolute amounts 
of the transcript for APPhgS were not determined since 
the PCRs were not performed in the presence of an 
internal standard. 
In contrast o neurons, astrocytcs in culture expressed 
not only APPhg5, but also the two isoforms with the 
Kunitz domain, APPTs, and APP,,O. APP,,, was the 
most abundant form in astrocytes (Fig. 3). Upon stimu- 
lation of the cells with bFGF (50 &ml) or CAMP (1 
mM) the expression pattern of APP remained un- 
changed, while this treatment altered the morphology 
and antigen expression of astrocytes in a way that re- 
sembled a reactive gliosis [14]. 
Furthermore, we analysed the APP splice pattern of 
microglia in culture. APP,5, and APP,,, were the major 
APP forms in microglial cells. Expression of APPhgS was 
only very sparse (Fig. 3). APP expression was not al- 
tered upon stimulation of the cells with IL-l/? (10 ng/ 
ml), macrophage colony-stimulating factor (100 U/ml) 
or LPS (10 pg/ml) for 24 h. 
As oligodendrocytes are another major cell type in 
the brain we examined if oligodendrocytes in culture 
Astrocytes Microglio 
Fig. 3. PCR analysis oT APP mRNAs in astrocylus and micro&a. 
Astrocyrcs were grown in the absence of serum or in the prcsencc of
either 10% fetal calf serum, bFGF (50 nS/ml) or CAMP (1 mM). 
Microglial cells were stimulated with II-lp (10 ndml), M-CSF (100 
U/ml) or lipopolysaccharidc (LPS; 10 Erg/ml) for 24 h. 
express APP, using bipolar progenitor cells and differ- 
entiated oligodendrocytes (60% pure). Moreover, differ- 
entiated oligodendrocytes were enriched by density gra- 
dient chromatography (90% pure population). Fig. 4 
shows that all three samples mainly expressed APPeq5. 
The two isoforms with the Kunitz domain were found 
only ir; the 60% pure oligodendrocyte population. They 
were probably derived from astrocytes and microgiial 
cells present in these cultures. The APP,,$ seen here 
could not be of neuronal origin since only very few 
neurons, if any, were present in these cultures. 
4. DISCUSSION 
APP gene expression was investigated by RT-PCR in 
different types of primary neurons, astrocytes, micro- 
glial cells and oligodendrocytes. 
Pure neuron cultures derived from fetal rat brain ex- 
clusively expressed APP,+ The expression of this 
isoform was independent of the state of differentiation 
of the cells and of the time in culture. We did not inves- 
tigate neuronal cultures that were cultivated for more 
than 8 days since contaminating astrocytes proliferated 
with time and reduced the purity of the cultures. 
As described for other non-neuronal cells [2,25,26] 
APP7,0 and APPTS, were the major APP isoforms in 
astrocytes and microglia. In addition, we detected sig- 
nificant levels of APPm5 in astrocytcs, and small 
amounts in microglia. While it has been reported that 
astrocyte cultures did not express APP forms containing 
the Kunitz domain 1271, our study clearly demonstrated 
the expression of APPTTo and APPTSl in astrocytes. 
LeBlanc et al. [28] obtained similar results using North- 
ern blots and RNase protection assays. 
To mimic the in vivo situation of reactive gliosis, 
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87 bp- 
- APP695 
Fig. 4. PCR analysis of APP mRNAs in oligodendrocytes (obtained 
by pcrcoll density chromatography), bipolar precursor cells (O-2A) 
and oligodcndrocytes (obtained by the shaking method, 60% pure). 
astrocytcs were treated with bFGF or CAMP. This 
treatment imitates several of the effects described in 
reactive gliosis [Id]. The activation did not affect the 
splice pattern of APP. The same could be demonstrated 
for activated microglia in culture. These results indi- 
cated that glial activation did not involve an alteration 
of the splice pattern of APP mRNA. It is of particular 
interest that oligodendrocytes expressed the neuron- 
specific isoform, APP,,$, rather than the APP isoforms 
typical for non-ncuronal cells. Even the bipolar progen- 
itor cells (O-2A cells), that generate both oligodendro- 
cytes and type 2-astrocytes in culture [39], expressed 
only APP6g5. 
Our results contirmed the existence of a cell-type spe- 
cific post-transcriptional regulation of APP gene ex- 
pression at the level of splicing. Although the pattern of 
APP splicing is modified during the induction of a neu- 
ronal phenotype in various tumor cell lines [24,30,313, 
a specific splice pattern apparently does not depend on 
the state of differentiation or activation of the respective 
cell type. Therefore, it is reasonable to argue that a 
switch in APP splicing may not be responsible for the 
increased occurrence of APP,,, observed in AD cases. 
The observed shift to the APP isoforms containing the 
Kunitz domain may instead be explained by an elevated 
number of astrocytes and microglia due to reactive gli- 
osis and concomitant neuron loss. 
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